These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36045026)

  • 1. Epidemiology of opioid use in pregnancy.
    Cook JL
    Best Pract Res Clin Obstet Gynaecol; 2022 Dec; 85(Pt B):12-17. PubMed ID: 36045026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The opioid epidemic and neonatal abstinence syndrome in the USA: a review of the continuum of care.
    Pryor JR; Maalouf FI; Krans EE; Schumacher RE; Cooper WO; Patrick SW
    Arch Dis Child Fetal Neonatal Ed; 2017 Mar; 102(2):F183-F187. PubMed ID: 28073819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Maternal-Risk Factors Related to Neonatal Abstinence Syndrome in a Commercial Claims Database: 2011-2015.
    Dave CV; Goodin A; Zhu Y; Winterstein A; Wang X; Alrwisan A; Hartzema A
    Pharmacotherapy; 2019 Oct; 39(10):1005-1011. PubMed ID: 31361913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends of Neonatal Abstinence Syndrome Epidemic and Maternal Risk Factors in Florida.
    Wang X; Zhu Y; Dave CV; Alrwisan AA; Voils SA; Winterstein AG
    Pharmacotherapy; 2017 Jul; 37(7):806-813. PubMed ID: 28500694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. US Hospital Data About Neonatal Abstinence Syndrome and Maternal Opioid-Related Diagnoses-Reply.
    Hirai AH; Ko JY; Patrick SW
    JAMA; 2021 May; 325(20):2120. PubMed ID: 34032835
    [No Abstract]   [Full Text] [Related]  

  • 6. US Hospital Data About Neonatal Abstinence Syndrome and Maternal Opioid-Related Diagnoses.
    Meyer M; Metayer J
    JAMA; 2021 May; 325(20):2119-2120. PubMed ID: 34032837
    [No Abstract]   [Full Text] [Related]  

  • 7. Opioid Management in Pregnancy and Postpartum.
    Brown HL
    Obstet Gynecol Clin North Am; 2020 Sep; 47(3):421-427. PubMed ID: 32762927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding barriers to timely identification of infants at risk of neonatal opiate withdrawal syndrome.
    Howell MP; Smith AM; Lindsay EB; Drury SS
    J Matern Fetal Neonatal Med; 2021 Apr; 34(7):1161-1166. PubMed ID: 31195865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy and the Opioid Epidemic.
    Haycraft AL
    J Psychosoc Nurs Ment Health Serv; 2018 Mar; 56(3):19-23. PubMed ID: 29505087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of opioid dependence in the setting of pregnancy.
    Young JL; Martin PR
    Psychiatr Clin North Am; 2012 Jun; 35(2):441-60. PubMed ID: 22640765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse neonatal outcomes associated with maternal severe mental health diagnoses and opioid use.
    Ma J; Sahasranaman V; Kirby RS; Boaz T
    J Perinatol; 2020 Oct; 40(10):1497-1505. PubMed ID: 32753708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective, observational study on medication for opioid use disorder during pregnancy and risk for neonatal abstinence syndrome.
    Sujan A; Cleary E; Douglas E; Aujla R; Boyars L; Smith C; Guille C
    Fam Pract; 2022 Mar; 39(2):311-315. PubMed ID: 34537839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Women, Infants, and Opioids.
    Lowe NK
    J Obstet Gynecol Neonatal Nurs; 2017; 46(5):657-659. PubMed ID: 28802558
    [No Abstract]   [Full Text] [Related]  

  • 14. Prenatal Use of Medication for Opioid Use Disorder and Other Prescription Opioids in Cases of Neonatal Opioid Withdrawal Syndrome: North Carolina Medicaid, 2016-2018.
    Austin AE; Bona VD; Cox ME; Proescholdbell S; Fliss MD; Naumann RB
    Am J Public Health; 2021 Sep; 111(9):1682-1685. PubMed ID: 34383554
    [No Abstract]   [Full Text] [Related]  

  • 15. Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome.
    Gray TR; Choo RE; Concheiro M; Williams E; Elko A; Jansson LM; Jones HE; Huestis MA
    Addiction; 2010 Dec; 105(12):2151-9. PubMed ID: 20854338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study.
    Huybrechts KF; Bateman BT; Desai RJ; Hernandez-Diaz S; Rough K; Mogun H; Kerzner LS; Davis JM; Stover M; Bartels D; Cottral J; Patorno E
    BMJ; 2017 Aug; 358():j3326. PubMed ID: 28768628
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of Perinatal Opioid Use Disorder.
    Boyars L; Guille C
    Obstet Gynecol Clin North Am; 2018 Sep; 45(3):511-524. PubMed ID: 30092925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Practical Approach to Neonatal Opiate Withdrawal Syndrome.
    Devlin LA; Davis JM
    Am J Perinatol; 2018 Mar; 35(4):324-330. PubMed ID: 29100261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
    Tran TH; Griffin BL; Stone RH; Vest KM; Todd TJ
    Pharmacotherapy; 2017 Jul; 37(7):824-839. PubMed ID: 28543191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neonatal abstinence syndrome after maternal use of tramadol].
    de Wit D; Koomen-Botman I
    Ned Tijdschr Geneeskd; 2013; 157(9):A5610. PubMed ID: 23446156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.